Number of shares outstanding for Ionis Pharmaceuticals (IONS)

Number of shares outstanding as of September 2024 : 146,000,000

According to Ionis Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 146,000,000. At the end of 2024 the company had 146,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Ionis Pharmaceuticals from 1996 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.14 B	1.39%
2023	0.14 B	1.41%
2022	0.14 B	0.71%
2021	0.14 B	0.71%
2020	0.14 B	-0.71%
2019	0.14 B	2.4%
2018	0.13 B	10.32%
2017	0.12 B	2.87%
2016	0.12 B	0.96%
2015	0.12 B	1.66%
2014	0.11 B	1.81%
2013	0.11 B	14.69%
2012	0.10 B	1.56%
2011	99.68 M	0.49%
2010	99.19 M	0.89%
2009	98.32 M	2.56%
2008	95.86 M	14.2%
2007	83.94 M	14.07%
2006	73.58 M	14.83%
2005	64.08 M	11.91%
2004	57.26 M	3.11%
2003	55.54 M	1.52%
2002	54.7 M	24.71%
2001	43.86 M	14.1%
2000	38.44 M	34.26%
1999	28.63 M	14.55%
1998	25 M	-9.09%
1997	27.5 M	5.42%
1996	26.08 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
NRC Health NRC	23,871,000	-83.65%	🇺🇸 USA
Nymox Pharmaceutical NYMX	91,265,140	-37.49%	Bahamas

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions